Loop | Ludwig Kappos
loop.frontiersin.org
Frontiers Media S.A. All Rights Reserved. 0Share. Ludwig Kappos. Follow. Neurology. University Hospital Basel. Basel, Switzerland. Total views.
Ludwig Kappos | EXCEMED
www.excemed.org
Ludwig Kappos. From clinical trials to post-marketing studies: where is the gain? Neurology. Educational events. A world of opportunity for learning awaits. Live events.
Kappos fingolimod moa-clin_results_vfinal_buenosaires1a
www.slideshare.net
Sep 27, · Transcript. 1. Fingolimod (Gilenya):Mode of ActionandClinical Trial Results Prof. Ludwig Kappos Chair Neurology and Department of Biomedicine
Phase IIb data show that BG-12 significantly reduced brain lesions ...
www.sciencecodex.com
the future of relapsing-remitting MS treatment," said the study's primary investigator, Professor Ludwig Kappos, acting Chair of Neurology and Research Group Leader, Department of Biomedicine, University Hospital Basel, ...
Relation between functional brain imaging, cognitive ...link.springer.com › article
link.springer.com
60/62, 4055, Basel, Switzerland. Iris-Katharina Penner PhD & Klaus Opwis. University Hospital Basel, Dept. of Neurology, Basel, Switzerland. Ludwig Kappos.
Google Groups: Oral Compound Shown To Significantly Reduce Brain Lesion in PwMS
: ... primary investigator, Professor Ludwig Kappos, acting Chair of Neurology and
Google Groups: Long-Term Follow-Up Studies/Betaseron
: Ludwig Kappos, Dept. of Neurology, University Hospital in Basel, Switzerland. "
Google Groups: Betaferon/Reduced Relapse Rate
: ... with early MS," said Professor Ludwig Kappos, Department of Neurology
Google Blogs: PipelineReview.com - Biotech News & Online Store - New extension ...
The favorable longer term safety profile is consistent with results from the phase III studies," said Ludwig Kappos, Department of Neurology, University of Basel, Switzerland. "These observations in a large group of patients, ...
All web results to the name "Ludwig Kappos"
Ludwig Kappos, MSVirtual2020 – Highlights From ...touchneurology.com › conference-hub › ludwig-kappo...
touchneurology.com
We were delighted to speak with Ludwig Kappos (University Hospital Basel, University of Basel, Basel, Switzerland) about his highlights from ...
App for MS aims to capture elusive signals of progression ...www.mdedge.com › neurology › article › multiple-sclerosis
www.mdedge.com
In June, Ludwig Kappos, MD, the app study's senior researcher, co-authored an analysis of randomized trial data that argued for discarding the ...
Long-term prognostic value of longitudinal measurements of ...nn.neurology.org › content › tab-article-info
nn.neurology.org
Dieter A. Häring, Harald Kropshofer, Ludwig Kappos, Jeffrey A. Cohen, Anuja Shah, Rolf Meinert, David Leppert, Davorka Tomic, Jens Kuhle.
Disease Control in RRMS Transferring Treatment From Natalizumab to...
clinicaltrials.gov
Contact: Ludwig Kappos, Prof., MD, Principal Investigator: Ludwig Kappos, Prof., MD, Department of Neurology, University ...
NEDA-4 May Predict MS Outcomes Better Than NEDA-3 | MDedge Neurology
www.mdedge.com
Ludwig Kappos, MD. An Analysis of FREEDOMS Data. Dr. Kappos and colleagues examined data from the FREEDOMS extension studies, which compared ...
Oral fingolimod demonstrates reduced MS activity at end of
www.formularywatch.com
In addition, it is given conveniently in the form of a once-daily pill," said Ludwig Kappos, MD, Neurology-Neurosurgery, University Hospital, ...
Abstract: Timecourse of Treatment Effects of BG-12 (Dimethyl...
cmsc.confex.com
Ludwig Kappos, MD , University Hospital, Basel Neurology, Basel, Switzerland, Basel, Switzerland. Gavin Giovannoni, PhD , Queen Mary ...
Related search requests for Ludwig Kappos
Massimo Filippi Hans-Peter Hartung Giancarlo Comi | Ralf Gold Michel Clanet Marcus D'souza | Henrik Gensicke Cindy Lopez Claudia Wagner |
People Forename "Ludwig" (2707) Name "Kappos" (74) |
sorted by relevance / date